Impact assessment
Fees for Pharmaceutical Services: Impact Assessment
This initiative introduced in 2008, through Directions to NHS Primary Care Trusts (PCTs), a charging regime for applicants applying to provide NHS pharmaceutical services as a contribution towards the costs the NHS incurs in dealing with such applications.
This was published under the 2010 to 2015 Conservative and Liberal Democrat coalition government
Documents
PDF, 120KB, 13 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email publications@dh.gsi.gov.uk .
Please tell us what format you need. It will help us if you say what assistive technology you use.
PDF, 83.8KB, 9 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email publications@dh.gsi.gov.uk .
Please tell us what format you need. It will help us if you say what assistive technology you use.
Details
This IA (IA 5098) updates the previous 2008 impact assessment to take account of a review of that original initiative in 2009 and changes now being introduced to the main NHS (Pharmaceutical Services) Regulations from summer 2012 which govern entry to the NHS market.
Published 24 July 2012
GOV.UK
